Surgery Partners, Inc. 10 月 25 日 —— 据《金融时报》周日报道，总部位于美国的非营利医疗体系 Bon Secours Mercy Health 正处于后期谈判阶段，拟收购 Surgery Partners 的多数股权，该交易将使该公司估值（含债务）约为 60 亿美元。以下是一些细节：报道称，这项可能最早于周一宣布的潜在交易，将这家短期住院手术运营商的估值定在每股约 20 美元，援引了知情人士的话。
Surgery Partners, Inc. Oct 25 - US based not-for-profit health system Bon Secours Mercy Health is in late-stage talks to buy a majority stake in Surgery Partners in a deal which would value the company at roughly $6 billion including debt, the Financial Times reported on Sunday. Here are a few details: The potential, deal which could be announced as early as Monday, values the short-stay surgery operator at about $20 a share, the report said, citing people familiar with the matter Bon Secours Mercy Health and Surgery Partners did not immediately respond to Reuters request for comment outside regular business hours Bain Capital, its largest shareholder, will retain its almost 40 per cent shareholding in Surgery Partners as part of the take-private deal, the report added The potential deal would represent a 25.8% premium to Surgery Partners' last close of $15.9, as per LSEG data.
Bon Secours Mercy Health 和 Surgery Partners 在正常工作时间之外未立即回应路透社的置评请求。报道补充称，作为这项私有化交易的一部分，其最大股东贝恩资本将保留其在 Surgery Partners 近 40% 的股份。根据 LSEG 数据，该潜在交易较 Surgery Partners 昨收盘价 15.9 美元溢价 25.8%。
去年 6 月，Surgery Partners 拒绝了贝恩资本的私有化要约，称无法同意该私募股权集团设定的条款。
Surgery Partners rejected Bain Capital's take-private offer in June last year, saying it was unable to agree to the terms set by the private equity group